Wednesday, April 15, 2020

WUXI Sponsors COVID Advanced Biotech Webinar April 16: Janssen, Vir, Alnylam, Adaptive Biotech

On April 16, 2020, at 7-9 Pacific, 10-12 Eastern, WUXI is sponsoring its second in a series of online forums on advanced technologies for the COVID battle.

See the registration page for April 16 here.

- During the webinar, Wuxi mentioned there were 3600 pre-registrants and 1600 live Zoom viewers and "59,000 on iphone platforms" (minute 46).

Note: It looks like the first webinar, February 25, is online as archived video, here.

I've clipped the online agenda below; these times are Eastern Time.

AGENDA in EDT Time Zone

10:00 – 10:04am
Hui Cai, Vice President and Head of Content, WuXi AppTec

10:04 – 10:05am
Remembering the Lives Lost to COVID-19

10:05 – 10:25am
COVID-19: A Defining Moment
Jim Greenwood, CEO, Biotechnology Innovation Organization (BIO)
Moderated by Edward Hu, Co-CEO, WuXi AppTec

10:25 – 10:45am
Diagnosis: Lessons from the Battlefield
William Morice, President, Mayo Clinic Laboratories
Moderated by Carolyn Magill, CEO, Aetion*

10:45 – 11:35am :
Development in Time of Crisis

   Johan Van Hoof, Global Therapeutic Area Head IDV, Vaccines, Janssen Pharmaceuticals R&D and Managing Director, Janssen Vaccines & Prevention, B.V.
   Phil Pang, Chief Medical Officer, Vir Biotechnology
   John Maraganore, CEO, Alnylam Pharmaceuticals
   Chad Robins, CEO & Co-Founder, Adaptive Biotechnologies
Moderated by Steve Yang, EVP and CBO, WuXi AppTec

11:35 – 11:55am
The Future of Epidemic Readiness
Arnaud Bernaert, Head of Shaping the Future of Health and Healthcare, World Economic Forum
Moderated by Steve Usdin, Senior Editor and Head of Policy, BioCentury

11:55 – 12:05pm
Steve Bates, CEO, UK BioIndustry Association

Aeteon is a real world evidence health data company - here.